Clinical Trial Update: Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated rotigotine versus placebo for efficacy in advanced-stage idiopathic Parkinson's disease. The study is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Idiopathic Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-22